2025 annual financial data
Odyssey Therapeutics 2025 Operating income growth
Direct answer
Operating income growth was -19.18%.
Operating income was -161,156,000 USD and net income was -148,647,000 USD.
Operating cash flow was -129,468,000 USD.
Get free Odyssey Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,976,000 USD
- Operating income
- -161,156,000 USD
- Net income
- -148,647,000 USD
- Operating cash flow
- -129,468,000 USD